Cargando…

979. A Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacteriaceae Prevention Program at General Medicine Wards, Siriraj Hospital

BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) colonization is an important risk factor for CRE infection. Most of Infection prevention control (IC) strategies to reduce CRE colonization were recommended to implement in a private room setting. Data on effectiveness of IC program in genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Taweesuk, Apiradee, Rachakhom, Siriporn, Wangchinda, Walaiporn, Thamlikitkul, Visanu, Assanasen, Susan, Rattanaumpawan, Pinyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677231/
http://dx.doi.org/10.1093/ofid/ofad500.034
_version_ 1785150081216806912
author Taweesuk, Apiradee
Rachakhom, Siriporn
Wangchinda, Walaiporn
Thamlikitkul, Visanu
Assanasen, Susan
Rattanaumpawan, Pinyo
author_facet Taweesuk, Apiradee
Rachakhom, Siriporn
Wangchinda, Walaiporn
Thamlikitkul, Visanu
Assanasen, Susan
Rattanaumpawan, Pinyo
author_sort Taweesuk, Apiradee
collection PubMed
description BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) colonization is an important risk factor for CRE infection. Most of Infection prevention control (IC) strategies to reduce CRE colonization were recommended to implement in a private room setting. Data on effectiveness of IC program in general medicine wards is limited. METHODS: During February-October 2021, a cluster-randomized controlled trial was conducted among high risk for CRE-adult patients at six general medical wards, Siriraj Hospital. Six wards were randomized to receive either the standard IC care (sIC) or the enhanced CRE prevention program (eIC) plus sIC. The active CRE surveillance of stool or rectal swab specimen was performed in both groups within the first 72 hours of enrollment and then every 7 days. The eIC included a monthly healthcare education and feedback session, a real-time alert of CRE-acquisition from the active surveillance, and the CRE contact precaution visual reminder. The sIC included the cohorting and contact precaution of a CRE-acquisitioned patient, and a real-time alert of CRE-acquisition from the clinical specimen. RESULTS: There were 174 patients (with 1684 patient-days) in the intervention group and 189 patients (with 1517 patient-days) in the control group. Baseline characteristics were comparable between two groups. The cumulative incidence of CRE-acquisition was slightly lower in the intervention group (36.8% (64/174) vs. 46.6% (88/189);p=0.059). The incidence rate of CRE-acquisition was significantly lower in the intervention group (0.038 vs. 0.058;p=0.007). The median [range] of CRE-acquisition free time (6 days [1-73] vs. 5 days [1-81];p=0.84) were comparable. K. pneumoniae was the most common CRE pathogen isolated from the surveillance and clinical specimens. No difference in all-cause mortality and length of stay between the two groups was observed. CONCLUSION: The incidence of CRE acquisition at our institute was remarkably high. The eIC could reduce the incidence of CRE-acquisition and lengthen the CRE-acquisition free time. Future study should be done to explore the benefit on morbidity and mortality outcomes. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677231
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106772312023-11-27 979. A Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacteriaceae Prevention Program at General Medicine Wards, Siriraj Hospital Taweesuk, Apiradee Rachakhom, Siriporn Wangchinda, Walaiporn Thamlikitkul, Visanu Assanasen, Susan Rattanaumpawan, Pinyo Open Forum Infect Dis Abstract BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) colonization is an important risk factor for CRE infection. Most of Infection prevention control (IC) strategies to reduce CRE colonization were recommended to implement in a private room setting. Data on effectiveness of IC program in general medicine wards is limited. METHODS: During February-October 2021, a cluster-randomized controlled trial was conducted among high risk for CRE-adult patients at six general medical wards, Siriraj Hospital. Six wards were randomized to receive either the standard IC care (sIC) or the enhanced CRE prevention program (eIC) plus sIC. The active CRE surveillance of stool or rectal swab specimen was performed in both groups within the first 72 hours of enrollment and then every 7 days. The eIC included a monthly healthcare education and feedback session, a real-time alert of CRE-acquisition from the active surveillance, and the CRE contact precaution visual reminder. The sIC included the cohorting and contact precaution of a CRE-acquisitioned patient, and a real-time alert of CRE-acquisition from the clinical specimen. RESULTS: There were 174 patients (with 1684 patient-days) in the intervention group and 189 patients (with 1517 patient-days) in the control group. Baseline characteristics were comparable between two groups. The cumulative incidence of CRE-acquisition was slightly lower in the intervention group (36.8% (64/174) vs. 46.6% (88/189);p=0.059). The incidence rate of CRE-acquisition was significantly lower in the intervention group (0.038 vs. 0.058;p=0.007). The median [range] of CRE-acquisition free time (6 days [1-73] vs. 5 days [1-81];p=0.84) were comparable. K. pneumoniae was the most common CRE pathogen isolated from the surveillance and clinical specimens. No difference in all-cause mortality and length of stay between the two groups was observed. CONCLUSION: The incidence of CRE acquisition at our institute was remarkably high. The eIC could reduce the incidence of CRE-acquisition and lengthen the CRE-acquisition free time. Future study should be done to explore the benefit on morbidity and mortality outcomes. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677231/ http://dx.doi.org/10.1093/ofid/ofad500.034 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Taweesuk, Apiradee
Rachakhom, Siriporn
Wangchinda, Walaiporn
Thamlikitkul, Visanu
Assanasen, Susan
Rattanaumpawan, Pinyo
979. A Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacteriaceae Prevention Program at General Medicine Wards, Siriraj Hospital
title 979. A Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacteriaceae Prevention Program at General Medicine Wards, Siriraj Hospital
title_full 979. A Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacteriaceae Prevention Program at General Medicine Wards, Siriraj Hospital
title_fullStr 979. A Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacteriaceae Prevention Program at General Medicine Wards, Siriraj Hospital
title_full_unstemmed 979. A Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacteriaceae Prevention Program at General Medicine Wards, Siriraj Hospital
title_short 979. A Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacteriaceae Prevention Program at General Medicine Wards, Siriraj Hospital
title_sort 979. a cluster-randomized controlled trial of enhanced carbapenem-resistant enterobacteriaceae prevention program at general medicine wards, siriraj hospital
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677231/
http://dx.doi.org/10.1093/ofid/ofad500.034
work_keys_str_mv AT taweesukapiradee 979aclusterrandomizedcontrolledtrialofenhancedcarbapenemresistantenterobacteriaceaepreventionprogramatgeneralmedicinewardssirirajhospital
AT rachakhomsiriporn 979aclusterrandomizedcontrolledtrialofenhancedcarbapenemresistantenterobacteriaceaepreventionprogramatgeneralmedicinewardssirirajhospital
AT wangchindawalaiporn 979aclusterrandomizedcontrolledtrialofenhancedcarbapenemresistantenterobacteriaceaepreventionprogramatgeneralmedicinewardssirirajhospital
AT thamlikitkulvisanu 979aclusterrandomizedcontrolledtrialofenhancedcarbapenemresistantenterobacteriaceaepreventionprogramatgeneralmedicinewardssirirajhospital
AT assanasensusan 979aclusterrandomizedcontrolledtrialofenhancedcarbapenemresistantenterobacteriaceaepreventionprogramatgeneralmedicinewardssirirajhospital
AT rattanaumpawanpinyo 979aclusterrandomizedcontrolledtrialofenhancedcarbapenemresistantenterobacteriaceaepreventionprogramatgeneralmedicinewardssirirajhospital